Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) CFO Sells 17,289 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CFO Matthew Buckhalter sold 17,289 shares of the business’s stock in a transaction on Wednesday, December 31st. The stock was sold at an average price of $8.18, for a total transaction of $141,424.02. Following the transaction, the chief financial officer owned 455,320 shares in the company, valued at approximately $3,724,517.60. The trade was a 3.66% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Matthew Buckhalter also recently made the following trade(s):

• On Friday, January 2nd, Matthew Buckhalter sold 18,340 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.85, for a total transaction of $143,969.00.
• On Tuesday, December 30th, Matthew Buckhalter sold 17,448 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.36, for a total transaction of $145,865.28.

Aveanna Healthcare Stock Performance

Shares of AVAH stock traded down $0.09 on Friday, reaching $8.08. The stock had a trading volume of 2,526,966 shares, compared to its average volume of 1,076,101. Aveanna Healthcare Holdings Inc. has a 12 month low of $3.67 and a 12 month high of $10.32. The firm has a market capitalization of $1.69 billion, a price-to-earnings ratio of 22.44 and a beta of 2.06. The firm’s 50-day moving average is $8.92 and its two-hundred day moving average is $7.49. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. The firm had revenue of $450.53 million for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%. On average, research analysts expect that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current fiscal year.

Institutional Trading of Aveanna Healthcare

A number of institutional investors have recently bought and sold shares of AVAH. Summit Partners L P acquired a new position in shares of Aveanna Healthcare during the 2nd quarter worth approximately $50,477,000. AustralianSuper Pty Ltd bought a new stake in shares of Aveanna Healthcare in the third quarter valued at approximately $15,743,000. Vanguard Group Inc. boosted its stake in shares of Aveanna Healthcare by 34.7% in the third quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company’s stock valued at $35,850,000 after buying an additional 1,041,324 shares during the period. Hillsdale Investment Management Inc. acquired a new stake in Aveanna Healthcare during the third quarter worth approximately $7,922,000. Finally, Assenagon Asset Management S.A. bought a new position in Aveanna Healthcare during the 3rd quarter worth $7,356,000. Institutional investors own 87.96% of the company’s stock.

Wall Street Analyst Weigh In

AVAH has been the subject of several research reports. UBS Group raised their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the company a “neutral” rating in a report on Friday, November 7th. Zacks Research lowered shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 20th. Jefferies Financial Group lifted their target price on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a report on Tuesday, October 28th. BMO Capital Markets assumed coverage on shares of Aveanna Healthcare in a report on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price target on the stock. Finally, William Blair initiated coverage on shares of Aveanna Healthcare in a research report on Monday, December 8th. They set an “outperform” rating for the company. Five equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $10.69.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.